| Literature DB >> 35338421 |
Manon Isabelle Weyland1, Paul-Georg Jost-Brinkmann1, Theodosia Bartzela2.
Abstract
OBJECTIVES: The study aimed to survey current strategies against enamel demineralization during multibracket therapy (MBT) and guide a prevention concept based on existing scientific evidence.Entities:
Keywords: Demineralization; Fluoride; Multibracket appliance; Orthodontics; Prevention; White spot lesions
Mesh:
Substances:
Year: 2022 PMID: 35338421 PMCID: PMC8956138 DOI: 10.1007/s00784-022-04454-5
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Fig. 1Geographical distribution of the participants (in parenthesis: % of all respondents). The darker shades of blue correspond to the federal states with most participants
Frequencies (% of participants) for measures and materials used to prevent demineralization at the start of and during multibracket therapy
| Protocol for WSL prevention during multibracket therapy | Always (%) | Usually (%) | Sometimes (%) | Never (%) |
|---|---|---|---|---|
| Education of the current oral hygiene situation | 82.9 | 16.4 | 0.0 | 0.7 |
| Oral hygiene instruction | 73.5 | 23.1 | 2.7 | 0.7 |
| Electronic toothbrush | 17.8 | 37.0 | 32.9 | 12.3 |
| Flossing | 83.0 | 10.9 | 5.4 | 0.7 |
| Professional tooth cleaning | 54.5 | 27.6 | 15.2 | 2.8 |
| Dietary advice | 33.1 | 20.0 | 33.1 | 13.8 |
| Saliva germ count | 0.7 | 1.4 | 4.9 | 93.0 |
| Fluoride gel | 45.1 | 25.4 | 17.6 | 12.0 |
| Fluoride varnish | 26.8 | 28.2 | 25.4 | 19.7 |
| Fluoride foam | 2.3 | 0.0 | 12.0 | 85.7 |
| CHX varnish or gel | 7.2 | 11.6 | 39.9 | 41.3 |
| Sealant around brackets, | 39.0 | 14.7 | 9.6 | 36.8 |
| Sealant around brackets, | 18.6 | 15.0 | 20.0 | 46.4 |
| Lingual appliance or clear aligner instead of conventional labial MB for patients with HCR | 11.0 | 10.3 | 48.3 | 30.3 |
| Start MB only when adequate oral hygiene is in place | 68.7 | 25.2 | 5.4 | 0.7 |
| Referral to the general dentist | 40.7 | 33.1 | 19.3 | 6.9 |
| Warning letter to parents/guardians | 48.6 | 24.7 | 19.2 | 7.5 |
| Compromise orthodontic treatment outcome | 18.6 | 37.2 | 42.1 | 2.1 |
| Continue treatment with a removable appliance | 6.2 | 22.6 | 56.8 | 14.4 |
| Early removal of the MB | 21.1 | 35.4 | 42.9 | 0.7 |
HCR high caries risk, MB multibracket
Frequencies (% of participants) for application and advice of remineralizing agents during multibracket therapy
| Frequency | % | |
|---|---|---|
| At the beginning of treatment | 90 | 58.1 |
| During professional tooth cleaning | 70 | 45.2 |
| 3–4 × a year | 39 | 25.2 |
| 2 × a year | 30 | 19.4 |
| Never | 12 | 7.7 |
| At every appointment | 9 | 5.8 |
| Every 6–8 weeks | 6 | 3.9 |
| Fluoridated toothpaste | 134 | 86.5 |
| Fluoride gel once a week | 117 | 75.5 |
| Fluoride rinse 1–2 × daily | 46 | 29.7 |
| Fluoridated toothpaste with 5000 ppm F | 14 | 9.0 |
| 0,06% CHX rinse 1 − 2 × daily | 7 | 4.5 |
| No recommendation | 5 | 3.2 |
| Sealant around the brackets | 120 | 77.4 |
| Application of F or CHX gel or varnish more than 2 × a year | 39 | 25.2 |
| No preventive measures offered | 29 | 18.7 |
CHX chlorhexidine digluconate, F fluoride
Fig. 2Frequencies (% of participants) of recommended therapies for white spot lesions (WSL) after multibracket therapy
Frequencies (% of participants) for motivating methods taken during multibracket therapy
| Remotivating methods | Frequency | % |
|---|---|---|
| Education about the consequences of poor oral hygiene | 146 | 94.2 |
| Information (oral/written) about oral hygiene situation | 131 | 84.5 |
| Show photos of demineralized teeth | 115 | 74.2 |
| Regular photo documentation for re-motivation | 80 | 51.6 |
| Videos/visual demonstration of oral care | 56 | 36.1 |
| Text message reminding to use oral aids (dental floss, mouthwash, etc.) | 10 | 6.5 |
| Chat apps for sharing dental selfies | 1 | 0.6 |
Overview of the included systematic reviews and meta-analyses on the prevailing management and treatment strategies for WSL during and after multibracket therapy
| References | Type of study | Studies | Participants | Publication yrs | Time of intervention | Prevention material | Follow-up | Effect (95% CI) | Evidence/comment |
|---|---|---|---|---|---|---|---|---|---|
| Benson et al. (2019) [ | SR | 10 | 1798/any age | 2005–2019 | During MBT | 1. F-containing product (i.e., APF foam, gel, mouth rinse, varnish, HFT) 2. F-releasing glass bead device 3. F-releasing bonding material 1. No treatment with extra F (i.e., placebo foam/gel/mouth rinse/varnish, 1,450 ppm TP) 2. F mouth rinse 3. Light-cured composite resin | 17.6 to 24.5 m (until the day of debonding) | RR = 0.52 (0.14 to 1.93) RR = 0.26 (0.11 to 0.57) RR = 0.68 (0.46 to 1.00) | F varnish (insufficient evidence) 12,300 ppm F (APF foam) prof. applied every 6 to 8 w (low evidence), WSL: APF 13% <—> Placebo 51% 5,000 ppm F (HFT) decreasing the new WSL during MBT (low evidence), new WSL: 5000 ppm 18% <—> 1450–1500 ppm 27% |
| Tasios et al. (2019) [ | SR and meta-analysis | 23 | 1473/any age, average age 14.1 yrs | 1992–2017 | During MBT | 1. F-containing product (i.e., varnish, mouth rinse, F-releasing bonding material) 2. Any sealant 3. Active reminder (i.e., mobile-phone, applications and messages) 1. No treatment with extra F (i.e., no varnish, 1,450 ppm TP, F drinking water, resin adhesive) 2. No sealant 3. No reminder | 3 to 26.7 m (mid-MBT or directly after debonding) | RR = − 0.32 (− 0.44 to − 0.21) RR = 0.77 (0.63 to 0.95) RR = 0.44 (0.31 to 0.64) | F varnish: prof. applied every 6 to 12 w reduce WSL incidence: F varnish 27% <—> no varnish 59% (low evidence) Flat surface sealant (insufficient evidence) Active patient reminder: 1x/w to 1x/m reduce WSL incidence: active patient reminder 26% <—> no reminder 60% (low evidence) |
| Höchli et al. (2017) [ | SR and meta-analysis | 20 | 942/any age, average age 16.1 yrs | 2006–2016 | Directly after debonding or up to 14 yrs. in retention | 1. CPP–ACP creams (with or without F) 2. External tooth bleaching 3. F-containing product (film, gel, mouth rinse or varnish) 4. RI 5. Miswak chewing sticks 6. Bioactive glass TP 1- 6. No treatment with extra F (i.e., conventional OH, no F TP, 1000–1450 ppm F TP) | 4 w to 6.5 m | MD = -0.80mm2 (-1.10 to -0.50mm2) SMD = − 0.92 (-1.32 to -0.52) | 22,600 ppm F varnish or 5% NaF varnish 1x/m promising results in reducing WSL (low evidence), WSL: varnish vs control |
APF acidulated phosphate fluoride, CI confidence interval, CPP-ACP casein phosphopeptide amorphous calcium phosphate, F fluoride, HFT high fluoridated toothpaste, MBT multibracket therapy, MD mean difference, m months, NaF sodium fluoride, nr. number, OH oral hygiene, Prof. applied professionally applied, RI resin infiltration, RR risk ratio, SMD standardized mean difference, SR systematic review, TP toothpaste, yrs. years, w weeks, WSL white spot lesions